Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2011

01.10.2011 | Original Article

Fecal Detection of Mycobacterium avium Paratuberculosis Using the IS900 DNA Sequence in Crohn’s Disease and Ulcerative Colitis Patients and Healthy Subjects

verfasst von: Anna Tuci, Francesca Tonon, Lucia Castellani, Alessandro Sartini, Giulia Roda, Margherita Marocchi, Alessandra Caponi, Alessandra Munarini, Giancarlo Rosati, Giampaolo Ugolini, Lorenzo Fuccio, Michele Scagliarini, Franco Bazzoli, Andrea Belluzzi

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

Background and Aim

Despite the increasing evidence of MAP/DNA isolation in Crohn’s disease (CD), its potential pathogenetic role remains unclear. To further clarify the possible relationship between MAP and CD, we investigated the presence of IS900 DNA fragment in feces from Crohn’s disease and ulcerative colitis (UC) patients and from healthy controls (HC).

Methods

Stool samples were collected from 31 CD, 20 UC, and 23 HC and stored at −20°C in 200-mg aliquots. DNA was extracted. MAP presence was detected with a specific PCR amplifying a 409-bp fragment from IS900. The specificity of PCR for IS900 was confirmed sequencing three positive products. Statistical analysis was performed using the Chi-square test.

Results

Twenty-one of 31 CD (68%), 13 of 20 UC (65%) and 11 of 23 HC (48%) were MAP-positive (CD vs. HC: p = ns; UC vs. HC: p = ns). With the limits of a small sample size, the IS900-positive percentage in CD and UC was higher than HC, although the difference was not statistically significant.

Conclusions

The possibility to track the MAP presence in human feces represents a new approach to the “MAP hypothesis”. Detection of MAP DNA in feces is very common, reaching very high prevalence both in CD and in UC and even in HC. Our findings seem consistent with a high prevalence of MAP asymptomatic infection among the general population and so the possible involvement of MAP in CD pathogenesis could be linked to a specific immune defective response.
Literatur
1.
Zurück zum Zitat Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. JAMA. 1932;99:1323–1329. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. JAMA. 1932;99:1323–1329.
2.
Zurück zum Zitat Greenstein RJ. Is Crohn’s disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne’s disease. Lancet Infect Dis. 2003;3:507–514.PubMedCrossRef Greenstein RJ. Is Crohn’s disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne’s disease. Lancet Infect Dis. 2003;3:507–514.PubMedCrossRef
3.
Zurück zum Zitat Chiodini RJ. Crohn’s disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol Rev. 1989;2:90–117. Review.PubMed Chiodini RJ. Crohn’s disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol Rev. 1989;2:90–117. Review.PubMed
4.
Zurück zum Zitat Chiodini RJ, Van Kruiningen HJ, Thayer WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn’s disease. Dig Dis Sci. 1984;29:1073–1079.PubMedCrossRef Chiodini RJ, Van Kruiningen HJ, Thayer WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn’s disease. Dig Dis Sci. 1984;29:1073–1079.PubMedCrossRef
5.
Zurück zum Zitat Motiwala AS, Strother M, Amonsin A, et al. Molecular epidemiology of Mycobacterium avium subsp. paratuberculosis: evidence for limited strain diversity, strain sharing, and identification of unique targets for diagnosis. J Clin Microbiol. 2003;41:2015–2026.PubMedCrossRef Motiwala AS, Strother M, Amonsin A, et al. Molecular epidemiology of Mycobacterium avium subsp. paratuberculosis: evidence for limited strain diversity, strain sharing, and identification of unique targets for diagnosis. J Clin Microbiol. 2003;41:2015–2026.PubMedCrossRef
6.
Zurück zum Zitat Green EP, Tizard ML, Moss MT, et al. Sequence and characteristics of IS900, an insertion element identified in a human Crohn’s disease isolate of Mycobacterium paratuberculosis. Nucleic Acids Res. 1989;17:9063–9073.PubMedCrossRef Green EP, Tizard ML, Moss MT, et al. Sequence and characteristics of IS900, an insertion element identified in a human Crohn’s disease isolate of Mycobacterium paratuberculosis. Nucleic Acids Res. 1989;17:9063–9073.PubMedCrossRef
7.
Zurück zum Zitat Kirkwood CD, Wagner J, Boniface K, et al. Mycobacterium avium subspecies paratuberculosis in children with early onset Crohn’s disease. Inflamm Bowel Dis. 2009;15:1643–1655.PubMedCrossRef Kirkwood CD, Wagner J, Boniface K, et al. Mycobacterium avium subspecies paratuberculosis in children with early onset Crohn’s disease. Inflamm Bowel Dis. 2009;15:1643–1655.PubMedCrossRef
8.
Zurück zum Zitat Lee A, Griffiths TA, Parab RS, et al. Association of Mycobacterium avium subspecies paratuberculosis with Crohn disease in pediatric patients. J Pediatr Gastroenterol Nutr. 2011;52:170–174.PubMedCrossRef Lee A, Griffiths TA, Parab RS, et al. Association of Mycobacterium avium subspecies paratuberculosis with Crohn disease in pediatric patients. J Pediatr Gastroenterol Nutr. 2011;52:170–174.PubMedCrossRef
9.
Zurück zum Zitat Wagner J, Sim W, Bishop RF, Catto-Smith AG, Cameron DJ, Kirkwood CD. Mycobacterium avium subspecies paratuberculosis in children with early onset crohn’s disease: a longitudinal follow-up study. Inflamm Bowel Dis. 2011; [Epub ahead of print]. Wagner J, Sim W, Bishop RF, Catto-Smith AG, Cameron DJ, Kirkwood CD. Mycobacterium avium subspecies paratuberculosis in children with early onset crohn’s disease: a longitudinal follow-up study. Inflamm Bowel Dis. 2011; [Epub ahead of print].
10.
Zurück zum Zitat Selby W, Pavli P, Crotty B, et al. Antibiotics in Crohn’s disease study group. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s disease. Gastroenterology. 2007;132:2313–2319. Epub Mar 21 2007.PubMedCrossRef Selby W, Pavli P, Crotty B, et al. Antibiotics in Crohn’s disease study group. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s disease. Gastroenterology. 2007;132:2313–2319. Epub Mar 21 2007.PubMedCrossRef
11.
Zurück zum Zitat Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–444.PubMed Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–444.PubMed
12.
Zurück zum Zitat Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29–32.PubMedCrossRef Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29–32.PubMedCrossRef
13.
Zurück zum Zitat Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28:495–503.PubMed Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28:495–503.PubMed
14.
Zurück zum Zitat Whittington RJ, Marsh I, Turner MJ, et al. Rapid detection of Mycobacterium paratuberculosis in clinical samples from ruminants and in spiked environmental samples by modified BACTEC 12B radiometric culture and direct confirmation by IS900 PCR. J Clin Microbiol. 1998;36:701–707.PubMed Whittington RJ, Marsh I, Turner MJ, et al. Rapid detection of Mycobacterium paratuberculosis in clinical samples from ruminants and in spiked environmental samples by modified BACTEC 12B radiometric culture and direct confirmation by IS900 PCR. J Clin Microbiol. 1998;36:701–707.PubMed
15.
Zurück zum Zitat Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn’s disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7:607–613. Review.PubMedCrossRef Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn’s disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7:607–613. Review.PubMedCrossRef
16.
Zurück zum Zitat Abubakar I, Myhill D, Aliyu SH, Hunter PR. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn’s disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis. 2008;14:401–410.PubMedCrossRef Abubakar I, Myhill D, Aliyu SH, Hunter PR. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn’s disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis. 2008;14:401–410.PubMedCrossRef
17.
Zurück zum Zitat Sanderson JD, Moss MT, Tizard ML, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn’s disease tissue. Gut. 1992;33:890–896.PubMedCrossRef Sanderson JD, Moss MT, Tizard ML, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn’s disease tissue. Gut. 1992;33:890–896.PubMedCrossRef
18.
Zurück zum Zitat Bull TJ, McMinn EJ, Sidi-Boumedine K. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn’s disease. J Clin Microbiol. 2003;41:2915–2923.PubMedCrossRef Bull TJ, McMinn EJ, Sidi-Boumedine K. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn’s disease. J Clin Microbiol. 2003;41:2915–2923.PubMedCrossRef
19.
Zurück zum Zitat Sechi LA, Scanu AM, Molicotti P, et al. Detection and isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn’s disease in Sardinia. Am J Gastroenterol. 2005;100:1529–1536.PubMedCrossRef Sechi LA, Scanu AM, Molicotti P, et al. Detection and isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn’s disease in Sardinia. Am J Gastroenterol. 2005;100:1529–1536.PubMedCrossRef
20.
Zurück zum Zitat Autschbach F, Eisold S, Hinz U, et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn’s disease. Gut. 2005;54:944–949.PubMedCrossRef Autschbach F, Eisold S, Hinz U, et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn’s disease. Gut. 2005;54:944–949.PubMedCrossRef
21.
Zurück zum Zitat Romero C, Hamdi A, Valentine JF, Naser SA. Evaluation of surgical tissue from patients with Crohn’s disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflamm Bowel Dis. 2005;11:116–125.PubMedCrossRef Romero C, Hamdi A, Valentine JF, Naser SA. Evaluation of surgical tissue from patients with Crohn’s disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflamm Bowel Dis. 2005;11:116–125.PubMedCrossRef
22.
Zurück zum Zitat Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn’s disease. Lancet. 2004;364:1039–1044.PubMedCrossRef Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn’s disease. Lancet. 2004;364:1039–1044.PubMedCrossRef
23.
Zurück zum Zitat Bentley RW, Keenan JI, Gearry RB, Kennedy MA, Barclay ML, Roberts RL. Incidence of Mycobacterium avium subspecies paratuberculosis in a population-based cohort of patients with Crohn’s disease and control subjects. Am J Gastroenterol. 2008;103:1168–1172. Epub Mar 26 2008.PubMedCrossRef Bentley RW, Keenan JI, Gearry RB, Kennedy MA, Barclay ML, Roberts RL. Incidence of Mycobacterium avium subspecies paratuberculosis in a population-based cohort of patients with Crohn’s disease and control subjects. Am J Gastroenterol. 2008;103:1168–1172. Epub Mar 26 2008.PubMedCrossRef
24.
Zurück zum Zitat Parrish NM, Radcliff RP, Brey BJ, et al. Absence of Mycobacterium avium subsp. paratuberculosis in Crohn’s patients. Inflamm Bowel Dis. 2009;15:558–565.PubMedCrossRef Parrish NM, Radcliff RP, Brey BJ, et al. Absence of Mycobacterium avium subsp. paratuberculosis in Crohn’s patients. Inflamm Bowel Dis. 2009;15:558–565.PubMedCrossRef
25.
Zurück zum Zitat Juste RA, Elguezabal N, Pavón A, et al. Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls. Int J Infect Dis. 2009;13:247–254. Epub Oct 15 2008.PubMedCrossRef Juste RA, Elguezabal N, Pavón A, et al. Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls. Int J Infect Dis. 2009;13:247–254. Epub Oct 15 2008.PubMedCrossRef
26.
Zurück zum Zitat Sartor RB. Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease? Gut. 2005;54:896–898.PubMedCrossRef Sartor RB. Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease? Gut. 2005;54:896–898.PubMedCrossRef
27.
Zurück zum Zitat Borody TJ, Leis S, Warren EF, Surace R. Treatment of severe Crohn’s disease using antimycobacterial triple therapy–approaching a cure? Dig Liver Dis. 2002;34:29–38.PubMedCrossRef Borody TJ, Leis S, Warren EF, Surace R. Treatment of severe Crohn’s disease using antimycobacterial triple therapy–approaching a cure? Dig Liver Dis. 2002;34:29–38.PubMedCrossRef
28.
Zurück zum Zitat Grant IR, Ball HJ, Rowe MT. Incidence of Mycobacterium paratuberculosis in bulk raw and commercially pasteurized cows’ milk from approved dairy processing establishments in the United Kingdom. Appl Environ Microbiol. 2002;68:2428–2435.PubMedCrossRef Grant IR, Ball HJ, Rowe MT. Incidence of Mycobacterium paratuberculosis in bulk raw and commercially pasteurized cows’ milk from approved dairy processing establishments in the United Kingdom. Appl Environ Microbiol. 2002;68:2428–2435.PubMedCrossRef
29.
Zurück zum Zitat Eltholth MM, Marsh VR, Van Winden S, Guitian FJ. Contamination of food products with Mycobacterium avium paratuberculosis: a systematic review. J Appl Microbiol. 2009;107:1061–1071.PubMedCrossRef Eltholth MM, Marsh VR, Van Winden S, Guitian FJ. Contamination of food products with Mycobacterium avium paratuberculosis: a systematic review. J Appl Microbiol. 2009;107:1061–1071.PubMedCrossRef
30.
Zurück zum Zitat Abubakar I, Myhill J, Hart AR, et al. A case-control study of drinking water and dairy products in Crohn’s disease–further investigation of the possible role of Mycobacterium avium paratuberculosis. Am J Epidemiol. 2007;165:776–783.PubMedCrossRef Abubakar I, Myhill J, Hart AR, et al. A case-control study of drinking water and dairy products in Crohn’s disease–further investigation of the possible role of Mycobacterium avium paratuberculosis. Am J Epidemiol. 2007;165:776–783.PubMedCrossRef
Metadaten
Titel
Fecal Detection of Mycobacterium avium Paratuberculosis Using the IS900 DNA Sequence in Crohn’s Disease and Ulcerative Colitis Patients and Healthy Subjects
verfasst von
Anna Tuci
Francesca Tonon
Lucia Castellani
Alessandro Sartini
Giulia Roda
Margherita Marocchi
Alessandra Caponi
Alessandra Munarini
Giancarlo Rosati
Giampaolo Ugolini
Lorenzo Fuccio
Michele Scagliarini
Franco Bazzoli
Andrea Belluzzi
Publikationsdatum
01.10.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1699-6

Weitere Artikel der Ausgabe 10/2011

Digestive Diseases and Sciences 10/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.